Vicente Pallarés Carratalá-rekin lankidetzan egindako argitalpenak (21)

2024

  1. Achievement of LDL-Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA-AP Study

    Cardiovascular Therapeutics, Vol. 2024

  2. Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain

    Frontiers in Cardiovascular Medicine, Vol. 11

2023

  1. Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 3

  2. Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study

    Medicina (Lithuania), Vol. 59, Núm. 10

2022

  1. Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review

    Semergen: revista española de medicina de familia, Núm. 4, pp. 275-292

  2. Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review

    Semergen, Vol. 48, Núm. 4, pp. 275-292

  3. Los péptidos natriuréticos en el diagnóstico de la insuficiencia cardíaca en atención primaria: Art. 101812

    Semergen: revista española de medicina de familia, Núm. 7, pp. 9-9

  4. Posicionamiento SEMERGEN en el abordaje de la insuficiencia cardíaca crónica en atención primaria

    Semergen: revista española de medicina de familia, Núm. 2, pp. 106-123

  5. SEMERGEN positioning on approaching chronic heart failure in primary care

    Semergen, Vol. 48, Núm. 2, pp. 106-123

  6. The natriuretic peptides in the diagnosis of heart failure in primary care setting

    Semergen, Vol. 48, Núm. 7

  7. Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. Manejo del paciente con dislipidemia en España. Proyecto Cardio Right Care Control del Riesgo Cardiovascular

    Semergen: revista española de medicina de familia, Núm. 1, pp. 28-37

  2. Recomendaciones para mejorar el control lipídico en pacientes en prevención primaria. Documento de consenso de la Sociedad Española de Cardiología

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 118-128

  3. Recommendations to improve lipid control in primary prevention patients. A consensus document of the Spanish Society of Cardiology

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 118-128

  4. Recommendations to improve lipid control in primary prevention patients. A consensus document of the Spanish Society of Cardiology

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 208-217

  5. Vacuna COVID-19 y pacientes anticoagulados por alto riesgo cardiovascular. Recomendaciones SEMERGEN

    Semergen: revista española de medicina de familia, Núm. 1, pp. 1-3

2020

  1. Telemedicine consultation for the clinical cardiologists in the era of COVID-19: present and future. Consensus document of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 910-918

2018

  1. Programa MICCAP (Manejo de la Insuficiencia Cardiaca en Cardiología y en Atención Primaria): mejorando el manejo del paciente con insuficiencia cardiaca

    Semergen: revista española de medicina de familia, Núm. 8, pp. 572-578

2015

  1. Resistant arterial hypertension in Primary Care patients in Spain. PRESCAP Study 2010

    Semergen, Vol. 41, Núm. 3, pp. 123-130

2014

  1. Blood pressure control and management of very elderly patients with hypertension in primary care settings in Spain

    Hypertension Research, Vol. 37, Núm. 2, pp. 166-171